Together, these intriguing findings suggest that higher NHSL1 expression in baseline tumors may reflect an initial response to NAC; however, it is likely associated with an overall unfavorable prognosis in BC patients treated with NAC followed by surgery. The gene discussed is NHSL1; the disease is breast cancer.